PCRX vs COLL

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Jun 24, 2026

PCRX

64.1
AI Score
VS
PCRX Wins

COLL

60.6
AI Score

Investment Advisor Scores

PCRX

64score
Recommendation
BUY

COLL

61score
Recommendation
BUY

AI Analyst Insights

Detailed Metrics Comparison

Metric PCRX COLL Winner
Forward P/E 7.7519 4.6577 COLL
PEG Ratio 11.2121 0 Tie
Revenue Growth 5.0% 8.9% COLL
Earnings Growth -30.0% -46.6% PCRX
Tradestie Score 64.1/100 60.6/100 PCRX
Profit Margin 0.7% 9.4% COLL
Beta 1.00 1.00 Tie
AI Recommendation BUY BUY Tie

Frequently Asked Questions

Based on our detailed analysis, PCRX is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.